Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CDNF Antikörper (AA 129-141)

Der Kaninchen Polyklonal anti-CDNF Antikörper (ABIN7886750) detektiert spezifisch CDNF in WB, IHC und IF. Dieser Antikörper reagiert spezifisch mit Proben aus Human.
Produktnummer ABIN7886750
1.184,62 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 8 bis 9 Werktagen

Kurzübersicht für CDNF Antikörper (AA 129-141) (ABIN7886750)

Target

Alle CDNF Antikörper anzeigen
CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))

Reaktivität

  • 36
  • 18
  • 16
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 40
  • 9
  • 1
Kaninchen

Klonalität

  • 40
  • 10
Polyklonal

Konjugat

  • 32
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CDNF Antikörper ist unkonjugiert

Applikation

  • 30
  • 22
  • 14
  • 13
  • 13
  • 13
  • 12
  • 8
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
  • Bindungsspezifität

    • 15
    • 5
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 129-141

    Verwendungszweck

    A Rabbit Polyclonal Antibody to Cerebral Dopamine Neurotrophic Factor

    Kreuzreaktivität

    Human, Maus

    Kreuzreaktivität (Details)

    Not recommended for rat samples.

    Homologie

    Mouse - 10,13 amino acid residues identical

    Produktmerkmale

    Anti-CDNF Antibody is directed against an epitope of human CDNF. Anti-CDNF Antibody (ABIN7043031, ABIN7044785 and ABIN7044786) can be used in western blot and immunohistochemistry applications. It has been designed to recognize CDNF from mouse and human samples. The antibody will not recognize CDNF from rat samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    (C)EKTLDLASVDLRK, corresponding to amino acid residues 129-141 of human CDNF

    Isotyp

    IgG
  • Applikationshinweise

    WB: 1:200-1:500

    FC: The optimal concentration should be determined by the user

    ICC: The optimal concentration should be determined by the user

    IHC: 1:300

    IP: The optimal concentration should be determined by the user

    Kommentare

    Negative Control: (ABIN7235051)

    Blocking Peptide: (ABIN7235051)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    25 μL, 50 μL or 0.2 mL double distilled water (DDW), depending on the sample size.

    Konzentration

    0.8 mg/mL

    Buffer

    PBS pH 7.4, 1 % BSA with 0.05 % sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C
  • Target

    CDNF (Cerebral Dopamine Neurotrophic Factor (CDNF))

    Andere Bezeichnung

    CDNF

    Hintergrund

    Synonyms: Cerebral dopamine neurotrophic factor, Arginine-rich mutated in early stage tumors-like 1, ARMET-like protein 1, ARMETL1

    Description: Neurotropic factors (NTFs) comprise an important group of secreted proteins regulating the life cycle of neurons during development. NTFs prevent apoptosis and control the number of neurons innervating a target tissue. NTFs also regulate migration, differentiation and maturation of postmitotic neuronal precursors and promote the regeneration of neurons after injury.Cerebral dopamine neurotrophic factor (CDNF) is a member of a sub-family of NTF proteins. The premature form of the protein consists of 187 amino acids while the mature form contains 161 residues. CDNF has a saposin-like N-terminal domain and an unstructured carboxy C-terminal domain with an intradomain cysteine bridge in a CXXC motif. Notably, saposin-like proteins interact with lipids, suggesting that CDNF's N-terminal may also interact with lipids. The saposin-like domain of CDNF crystalizes as a dimer at pH 4.6. It is presumed that CDNF functions upon synthesis and secretion since it does not contain prosequences for enzymatic activation.When CDNF is injected into the striatum of rats after the injection of 6-OHDA (6-OHDA leads to protracted retrograde degeneration of the nigrostriatal pathway) it significantly reduces amphetamine-induced rotational behavior and protects tyrosine hydroxylase (TH) positive dopaminergic cell bodies in the SN and TH-positive fibers in the striatum. In addition, CDNF had showed neurorestorative effects in the same animal model.Currently it is still unknown if CDNF also affects other types of neurons in the CNS or whether it has any effect on the PNS. It is also not clear to which target molecule CDNF binds and what signaling pathways it activates. CDNF might serve as a therapeutic agent for neurodegenerative diseases1.

    Gen-ID

    441549

    NCBI Accession

    NM_001029954

    UniProt

    Q49AH0
Sie sind hier:
Chat with us!